Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,268,688
  • Shares Outstanding, K 32,715
  • Annual Sales, $ 566,770 K
  • Annual Income, $ 48,160 K
  • 60-Month Beta 0.94
  • Price/Sales 2.12
  • Price/Cash Flow 3.48
  • Price/Book 5.66
Trade COLL with:

Options Overview Details

View History
  • Implied Volatility 50.31% ( +9.49%)
  • Historical Volatility 35.95%
  • IV Percentile 47%
  • IV Rank 40.56%
  • IV High 88.09% on 09/21/23
  • IV Low 24.53% on 12/08/23
  • Put/Call Vol Ratio 0.02
  • Today's Volume 55
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 1,221
  • Open Int (30-Day) 1,150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.54
  • Number of Estimates 3
  • High Estimate 1.61
  • Low Estimate 1.41
  • Prior Year 1.21
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.07 +10.58%
on 09/10/24
39.28 -1.27%
on 09/18/24
+3.52 (+9.98%)
since 08/16/24
3-Month
31.12 +24.61%
on 06/20/24
39.58 -2.02%
on 07/30/24
+6.63 (+20.62%)
since 06/18/24
52-Week
20.95 +85.11%
on 10/27/23
40.95 -5.30%
on 03/28/24
+16.43 (+73.51%)
since 09/18/23

Most Recent Stories

More News
Collingwood Announces Non-Brokered Private Placement and Board Appointment

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 38.78 (+3.75%)
Collingwood Announces Director Resignation

VANCOUVER, BC / ACCESSWIRE / July 25, 2024 / Collingwood Resources Corporation (TSXV:COLL.P) (the "Company") announces that Jay Sujir has resigned from the Company's Board of Directors effective today....

COLL : 38.78 (+3.75%)
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall

DBX : 24.49 (-0.57%)
PGNY : 24.44 (-1.53%)
NTRA : 127.10 (-0.09%)
MTD : 1,402.69 (+1.39%)
AKAM : 97.41 (-0.47%)
COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 38.78 (+3.75%)
A Little Known Strategy Indicates These Three Companies Could Explode!

In this article, we look at price action strategies and uncover three companies with the potential for a breakout.

VSEC : 88.38 (+0.92%)
BAH : 154.51 (-0.61%)
COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 38.78 (+3.75%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 38.78 (+3.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 41.56
2nd Resistance Point 40.42
1st Resistance Point 39.60
Last Price 38.78
1st Support Level 37.64
2nd Support Level 36.50
3rd Support Level 35.68

See More

52-Week High 40.95
Last Price 38.78
Fibonacci 61.8% 33.31
Fibonacci 50% 30.95
Fibonacci 38.2% 28.59
52-Week Low 20.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar